Global Microbiome Landscape Market Study 2021: Growing Research and Skyrocketing Venture Funding

Dublin, IRELAND


Dublin, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The "2021 Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering.

Catalyzed by growing research and skyrocketing venture funding, the Microbiome is at an inflection point

Spurred by landmark research projects & findings, powered by significant grant dollars, surging clinical trials, and historic levels of venture funding, the microbiome market is marching towards the mainstream.

Advances in next generation sequencing (NGS), informatics, computing power, gene editing, synthetic biology, and now proteomics and metabolomics have brought about this revolution. The microbiome is a rich and diverse area that influences a multitude of fields including diagnostics, therapeutics, food, agriculture, personal care/cosmetics, and the environment.

2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome research. In the year 2020, there were over 75K+ scientific publications, $1B+ grants awarded to microbiome research, 150 ongoing clinical trials, and $1.5B+ venture funding.

Does this mean that the microbiome market is evolving from being considered nascent to emerging/developing? Read the report to better understand these questions and get additional information about this transformational market with potential across an array of segments and notable companies.

This report highlights the state of the microbiome by rigorously assessing industry trends across publications, grants, clinical trials, and startup funding activity. Over 40K scientific publications, >3K grants, and 100s of trials and funding activities have been analyzed to provide firms with actionable business insights. The dataset behind the report is based on real-world evidence that will drive actionable business insights.

Follow trends over the years captured across publications, grants, clinical trials, and startup funding activity to power data driven marketing campaigns to fund raising to investor pitches, and business/corporate development activities. Tap into premium data sources that leverage NLP and relational search paradigm to uncover relevant data points, all in one package.

Key Topics Covered:

  • Introduction: Report Scope and Methodology
  • Microbiome Based Publication Analytics (2011-2020)
  • Microbiome Based Grants Analytics (2011-2020)
  • Microbiome Based Clinical Trial Analytics (2015-2020)
  • Microbiome Based Startup Activity (2015-2020)

Companies Mentioned

  • 4D Pharma Plc
  • Adare Pharmaceuticals
  • Afineur
  • Arranta Bio
  • AstraZeneca Plc
  • Computomics
  • CosmosID
  • Enterome Bioscience SA
  • Evolve BioSystems
  • Evolve Biosystems Inc
  • Finch Therapeutics
  • Indigo Ag
  • Intralytix
  • Joyn Bio
  • Kaleido Biosciences Inc
  • Karius
  • Lodo Therapeutics
  • Microbiome Diagnostics Partners
  • Nubiyota LLC
  • Nuritas
  • Perfect Day
  • Seres Therapeutics Inc
  • Summit Therapeutics Plc
  • Synlogic Inc
  • TargEDys
  • Vedanta Biosciences Inc
  • Viome
  • Vyome Therapeutics
  • National Natural Science Foundation of China (NSFC)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • European Commission (EC)
  • National Institute of General Medical Sciences (NIGMS)
  • National Cancer Institute (NCI)
  • Ministry of Science and Technology of the People's Republic of China (MOST)
  • National Center for Advancing Translational Sciences (NCATS)
  • National Heart Lung and Blood Institute (NHLBI)
  • Directorate for Biological Sciences (NSF BIO)
  • German Research Foundation (DFG)
  • European Research Council (ERC)
  • Japan Society for the Promotion of Science (JSPS)
  • Medical Research Council (MRC)
  • Natural Sciences and Engineering Research Council (NSERC)
  • Wellcome Trust (WT)
  • Ministry of Economy, Industry and Competitiveness (MINECO)
  • Canadian Institutes of Health Research (CIHR)
  • National Institute of Child Health and Human Development (NICHD)
  • Biotechnology and Biological Sciences Research Council (BBSRC)
  • National Institute of Environmental Health Sciences (NIEHS)
  • National Institute of Dental and Craniofacial Research (NIDCR)
  • National Council for Scientific and Technological Development (CNPq)
  • United States Department of Agriculture (USDA)
  • National Institute of Food and Agriculture (NIFA)
  • National Agency for Research (ANR )
  • Office of the Director (OD)
  • Chinese Academy of Sciences (CAS)
  • National Institute for Health Research (NIHR)
  • Swiss National Science Foundation (SNF)
  • National Research Foundation of Korea (NRF)
  • Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
  • Baylor College of Medicine
  • National Human Genome Research Institute (NHGRI)
  • Washington University in St. Louis (WUSTL)
  • University of Alabama at Birmingham (UAB)
  • Imperial College London
  • Harvard University
  • University of Pittsburgh
  • University of Chicago (UC)
  • Massachusetts General Hospital (MGH)
  • University of North Carolina at Chapel Hill (UNC)
  • University of Copenhagen (UCPH)
  • University of Michigan (UM)
  • Albert Einstein College of Medicine (AECOM)
  • University of California, San Diego (UCSD)
  • University of Cambridge
  • Flanders Institute for Biotechnology (VIB)
  • University of California, Los Angeles (UCLA)
  • Karolinska Institute (KI)
  • Queen's University Belfast (QUB)
  • King's College London (KCL)
  • University of Maryland, Baltimore (UMAB)
  • Icahn School of Medicine at Mount Sinai (MSSM)

For more information about this report visit https://www.researchandmarkets.com/r/oclx2e

 

Contact Data